DenosumabLung cancerimmunotherapychemotherapysouthern Taiwan Medical Centertyrosine kinase inhibitors
…o skeletal-related events (SREs) and a reduced quality of life. Denosumab delays the onset of SREs and is associated with improved overal…
11articles mentioning drugs
25drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Denosumab ×
Denosumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning Denosumab
11 articles · page 1 of 1denosumabREnal Disease-1haemodialysisfragility fracturelocal research ethics boardsClinical Trials Ontariokidney and metabolic bone disease
…a large-scale, efficiently run, pragmatic RCT to test whether a denosumab care pathway safely reduces the risk of fragility fracture in p…
benralizumabadalimumabmepolizumabadalimumab-relatedDenosumabVedolizumabBimekizumab
…pport co-prescribing. We describe our experience of prescribing benralizumab alongside non-SA MAbs at a tertiary centre.Methods We conducted…
DenosumabCapmatinibAtezolizumabCarboplatinAtezolezumabPemetrexedPemetexedCampatinibnon-small cell lung cancerNSCLC
…palliative ChT-IO with Atezolezumab + Pemetexed + Carboplatin + Denosumab followed by Maintenance Chemo IO with Pemetrexed + Atezolizumab…
alendronatedenosumabteriparatiderisedronatebisphosphonate
…vertebral, and humeral fractures was found with interruption in alendronate prescription for >2 years, and an increased risk of hip and cli…
98.5%
epoetin betadenosumabsecukinumabrheumatoid arthritischronic kidney diseaseprostate cancerosteoporosispharmacotherapy
…h-cost biologics such as denosumab (12%), secukinumab (8%), and epoetin beta (6%).Conclusion and Relevance The hospital pharmacy-led CMM pro…
denosumabteriperatideosteoporosissystemic lupus erythematosusSLEtertiary hospitalAntiresorptive or anabolic therapy
…y and were on therapeutic vacation period (2 teriperatide and 1 denosumab). Among classical risk factors, 12.1% were smokers (5% former a…
denosumabosteoporosisosteopenialow bone massanti-osteoporotic medication
…isk factors aged over 60 years. In the selection of medication, denosumab might be dominant. From the societal perspective, prevention fo…
zoledronic aciddenosumabcancerOsteonecrosis of the jawmalignant hypercalcaemiaradiotherapyosteoradionecrosisantiresorptive therapy
…s of the jaw is secondary to the use of antiresorptive therapy (zoledronic acid or denosumab) for bone metastases including management of malig…
denosumabright inferior parathyroid adenomaPHPTbrown tumoursprimary hyperparathyroidism
…ry, established the diagnosis of brown tumours. Preoperatively, denosumab was administered to control hypercalcaemia, and the patient sub…
denosumabbisphosphonatesBone metastasessurgeryCardiovascular and Interventional Radiological Society of EuropeNational Comprehensive Cancer Networkcryoablation
…mic therapies: Chemotherapy, hormonal therapy, bisphosphonates, denosumab, and targeted agents. - Radiation therapy: EBRT is the standard…